THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Eurasian Journal of Critical Care
Volume:1 Issue:3
THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS

THE NEW BIOMARKERS USED IN THE DIFFERENTIATION BETWEEN TRANSUDATE AND EXUDATE PLEURAL EFFUSIONS

Authors : Turgut TEKE, Kerim YESİLDAG

Pages : 105-110

View : 57 | Download : 14

Publication Date : 2019-12-23

Article Type : Review Paper

Abstract :Etiological diagnosis of pleural effusion is sometimes easy and sometimes very difficult challenge. In most of patients with pleural effusion, the symptoms, signs and laboratory data are not pathognomonic for etiologic diagnosis. In a patient with an undiagnosed pleural effusion, the first question to answer is whether the fluid is a transudate or an exudate. This is usually determined by means of Light`s criteria. In patients under diuretic treatment, Light`s criteria misclassify transudates as exudates, but the pleural fluid NT-pro-BNP levels usually is above 1500 pg/mL in pleural effusions associated with heart failure.
Keywords : pleural effusion, new biomarkers

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.